WCN26-6769 Efficacy of HIF-PHD Inhibitors for Renal Anemia in Peritoneal Dialysis Patients: A Single-Center Retrospective Study

Read full text Summarise with VIRAT
Authors: Genri Tagami, Kazuki Ogasawara, Makoto Yamaguchi, Kinashi Hiroshi, Takaaki Obayashi, Yasuhiko Ito, Takuji Ishimoto
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Renal anemia is a common and sometimes difficult-to-manage complication in peritoneal dialysis (PD) patients. Hypoxia-inducible factor prolyl hydroxylase (HIF-PHD) inhibitors are a novel therapeutic option, but data in PD patients remain limited. This study retrospectively evaluated the efficacy of HIF-PHD inhibitors in PD patients who had been switched from erythropoiesis-stimulating agents (ESAs).

Fields of Study & Subjects

Erythropoietin and Anemia Treatment Dialysis and Renal Disease Management Iron Metabolism and Disorders

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
104258–104258
Publication date
25 March 2026
Language
EN